<VariationArchive RecordType="classified" VariationID="4187" VariationName="NM_033629.6(TREX1):c.703_706dup (p.Thr236fs)" VariationType="Duplication" Accession="VCV000004187" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2021-01-30" MostRecentSubmission="2021-01-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19226" VariationID="4187">
      <GeneList>
        <Gene Symbol="ATRIP" FullName="ATR interacting protein" GeneID="84126" HGNC_ID="HGNC:33499" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446737" stop="48467645" display_start="48446737" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48488113" stop="48507053" display_start="48488113" display_stop="48507053" Strand="+" />
          </Location>
          <OMIM>606605</OMIM>
        </Gene>
        <Gene Symbol="ATRIP-TREX1" FullName="ATRIP-TREX1 readthrough" GeneID="111822955" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48446779" stop="48467645" display_start="48446779" display_stop="48467645" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TREX1" FullName="three prime repair exonuclease 1" GeneID="11277" HGNC_ID="HGNC:12269" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48465830" stop="48467645" display_start="48465830" display_stop="48467645" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48506918" stop="48509043" display_start="48506918" display_stop="48509043" Strand="+" />
          </Location>
          <OMIM>606609</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033629.6(TREX1):c.703_706dup (p.Thr236fs)</Name>
      <CanonicalSPDI>NC_000003.12:48467357:GTCA:GTCAGTCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48467357" stop="48467358" display_start="48467357" display_stop="48467358" variantLength="4" positionVCF="48467357" referenceAlleleVCF="G" alternateAlleleVCF="GGTCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48508756" stop="48508757" display_start="48508756" display_stop="48508757" variantLength="4" positionVCF="48508756" referenceAlleleVCF="G" alternateAlleleVCF="GGTCA" />
      </Location>
      <ProteinChange>T226fs</ProteinChange>
      <ProteinChange>T236fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_282" sequenceAccession="LRG_282">
            <Expression>LRG_282:g.6529_6532dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_282t1" sequenceAccession="LRG_282t1">
            <Expression>LRG_282t1:c.703_706dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_282p1" sequenceAccession="LRG_282p1" change="p.Thr236fs">
            <Expression>LRG_282p1:p.Thr236fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48508757_48508760dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48508757_48508760dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032166.4" sequenceAccession="NM_032166" sequenceVersion="4" change="c.*1804_*1807dup">
            <Expression>NM_032166.4:c.*1804_*1807dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130384.3" sequenceAccession="NM_130384" sequenceVersion="3" change="c.*1804_*1807dup" MANESelect="true">
            <Expression>NM_130384.3:c.*1804_*1807dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48467358_48467361dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48467358_48467361dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009820.2" sequenceAccession="NG_009820" sequenceVersion="2" change="g.6529_6532dup">
            <Expression>NG_009820.2:g.6529_6532dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033100.1" sequenceAccession="NG_033100" sequenceVersion="1" change="g.38500_38503dup">
            <Expression>NG_033100.1:g.38500_38503dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041782.1" sequenceAccession="NG_041782" sequenceVersion="1" change="g.25649_25652dup">
            <Expression>NG_041782.1:g.25649_25652dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_153405.1" sequenceAccession="NR_153405" sequenceVersion="1" change="n.4012_4015dup">
            <Expression>NR_153405.1:n.4012_4015dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007248.5" sequenceAccession="NM_007248" sequenceVersion="5" change="c.673_676dup">
            <Expression>NM_007248.5:c.673_676dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009179.2" sequenceAccession="NP_009179" sequenceVersion="2" change="p.Thr226fs">
            <Expression>NP_009179.2:p.Thr226fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033629.6" sequenceAccession="NM_033629" sequenceVersion="6" change="c.703_706dup" MANESelect="true">
            <Expression>NM_033629.6:c.703_706dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_338599.1" sequenceAccession="NP_338599" sequenceVersion="1" change="p.Thr236fs">
            <Expression>NP_338599.1:p.Thr236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271023.2" sequenceAccession="NM_001271023" sequenceVersion="2" change="c.*1804_*1807dup">
            <Expression>NM_001271023.2:c.*1804_*1807dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="606609.0009" DB="OMIM" />
        <XRef Type="rs" ID="1560113283" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033629.6(TREX1):c.703_706dup (p.Thr236fs) AND Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations" Accession="RCV000004406" Version="5">
        <ClassifiedConditionList TraitSetID="1152">
          <ClassifiedCondition DB="MedGen" ID="C1860518">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2007-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-01-30" MostRecentSubmission="2021-01-30">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17660820</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9371916</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1152" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6104" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations</ElementValue>
                <XRef ID="MONDO:0008641" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vasculopathy, retinal, with cerebral leukodystrophy</ElementValue>
                <XRef ID="Vasculopathy%2C+retinal%2C+with+cerebral+leukodystrophy/7360" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroretinal vasculopathy, hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CRV</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RVCLS</ElementValue>
                <XRef Type="MIM" ID="192315" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RVCL</ElementValue>
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">TREX1-Related Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a small-vessel disease that affects highly vascularized tissues including the retina, brain, liver, and kidneys. Age of onset is often between 35 and 50 years. The most common presenting finding is decreased visual acuity and/or visual field defects. Neurologic manifestations may include hemiparesis, facial weakness, aphasia, and hemianopsia. Migraines and seizures are less frequently described. Renal manifestations may include mild-to-moderate increase in serum creatinine and mild proteinuria; progression to end-stage renal disease (ESRD) is uncommon. Hepatic manifestations frequently include mildly elevated levels of alkaline phosphatase and gamma-glutamyltransferase (GGT). Less common findings include psychiatric disorders, hypertension, mild-to-moderate anemia, and Raynaud phenomenon.</Attribute>
                <XRef ID="NBK546576" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536185</ID>
                <ID Source="BookShelf">NBK546576</ID>
              </Citation>
              <XRef ID="247691" DB="Orphanet" />
              <XRef ID="3421" DB="Orphanet" />
              <XRef ID="63261" DB="Orphanet" />
              <XRef ID="71291" DB="Orphanet" />
              <XRef ID="C1860518" DB="MedGen" />
              <XRef ID="MONDO:0008641" DB="MONDO" />
              <XRef Type="MIM" ID="192315" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24578" SubmissionDate="2021-01-25" DateLastUpdated="2021-01-30" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606609.0009_VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS" title="TREX1, 4-BP DUP, 3727GTCA_VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS" />
        <ClinVarAccession Accession="SCV000024578" DateUpdated="2021-01-30" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a North American family of Chinese ancestry with autosomal dominant retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCLS; 192315), previously reported by Jen et al. (1997), Richards et al. (2007) identified heterozygosity for a 4-bp duplication (3727dupGTCA) at the C terminus of the TREX1 gene, resulting in a frameshift at thr249 (T249fs). The mutation was not found in 192 Caucasian, 192 Chinese, or 300 Dutch control alleles. In expression studies, the truncated protein retained exonuclease activity but lost normal perinuclear localization.</Attribute>
              <Citation>
                <ID Source="PubMed">9371916</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">17660820</ID>
              </Citation>
              <XRef DB="OMIM" ID="192315" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREX1" />
          </GeneList>
          <Name>TREX1, 4-BP DUP, 3727GTCA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, 3727GTCA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606609.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24578" TraitType="Disease" MappingType="Name" MappingValue="VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS" MappingRef="Preferred">
        <MedGen CUI="C1860518" Name="Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

